1 mg tirzepatide microdose Microdosing Benefits of GLP-1 Microdosing GLP-1
Description
Supplement Strategically Clinical studies support the importance of specialized supplementation for GLP-1 medication users [2]
In participants with type 2 diabetes, the average A1C reduction of 2.02% by week 48 is clinically significant enough that many would qualify for medication reduction under physician guidance
0.11%] and met the pre-specified non-inferiority margin (0.4%)
For celiac patients specifically, tirzepatide's mechanism bypasses the intestinal damage that complicates nutrient-based satiety signals
